| Product Name | MF | CAS | Details |
|---|
| Ethyl 2-methoxy-3,4,5,6-tetrahydropyridine-3-carboxylate | C9H15NO3 | 377082-44-5 | Details |
| CHORDC1 Blocking Peptide | Details |
| N2-Isobutyryl-O6-(4-pivaloyloxybenzyl)-7’-OH-N-trityl-morpholino guanine | C45H48N6O6 | 2072145-52-7 | Details |
| 1,3,6-Tri-O-galloylglucose | C27H24O18 | 18483-17-5 | Details |
| Chebulinic acid | C41H32O27 | 18942-26-2 | Details |
| 3-(2-Chloropyridin-3-yl)propan-1-ol | C8H10ClNO | 2044903-12-8 | Details |
| (1,3,3-Trimethylcyclohexyl)methanamine | C10H21N | 53060-57-4 | Details |
| N-Cbz-L-aspartic acid 1-benzyl ester | C19H19NO6 | 4779-31-1 | Details |
| Methyl 12-hydroxydodecanoate | C13H26O3 | 71655-36-2 | Details |
| WRKY67.1 antibody | Details |
| DACH2 Blocking Peptide | Details |
| [(1S,8R,10R,11R,16R)-5,11,15,15-Tetramethyl-6-oxo-2,7-dioxapentacyclo[8.8.0.01,3.04,8.011,16]octadec-4-en-14-yl] acetate | C22H30O5 | 122537-59-1 | Details |
| H-LPNAIGR-OH | Details |
| (-)-Tetrabenazine-d3 | C19H27NO3 | 1026016-84-1 | Details |
| 1-(1,1-Dimethylethyl) hydrogen?N-[20-(1,1-dimethylethoxy)-1,20-dioxoeicosyl]-L-glutamate | C33H61NO7 | 1119061-70-9 | Details |
| 4-(4-Bromo-3-(hydroxymethyl)phenoxy)benzonitrile | C14H10BrNO2 | 906673-45-8 | Details |
| CMX 001 - Bio-X ? | C27H52N3O7P | 444805-28-1 | Details |
| (1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol | C32H33N5O4 | 142217-77-4 | Details |
| 1,2-Dipalmitoyl-3-(N-palmitoyl-6'-amino-6'-deoxy-a-D-glucosyl)-sn-glycerol | C57H109NO10 | 843651-89-8 | Details |
| Betamethasone 17-butyrate | C26H35FO6 | 5534-14-5 | Details |
| Methyl 2-amino-4,5-dimethoxybenzoate | C10H13NO4 | 26759-46-6 | Details |
| 3-Bromo-1H,1aH,6H,6aH-cyclopropa[A]inden-1-amine hydrochloride | C10H11BrClN | 2060005-22-1 | Details |
| ST3GAL6 antibody | Details |
| H-Gly-Leu-Leu-Gly-OH | C16H30N4O5 | 104845-51-4 | Details |
| 1-(4-(1,2,4-triazolyl)phenyl))thiourea | C9H9N5S | 886499-48-5 | Details |
| tert-Butyl N-{[3-(methylamino)oxolan-3-yl]methyl}carbamate | C11H22N2O3 | 2247106-94-9 | Details |
| 4-Ethynyl-1-fluoro-2-(trifluoromethyl)benzene | C9H4F4 | 1233501-60-4 | Details |
| 2-(Phenyl-d5)-3,5-dimethylmorpholine Hydrochloride | C12H17NO | 1218345-44-8 | Details |
| N-(3-Aminopropyl)caprolactam Oxalic Acid | C9H18N2O | 24566-95-8 | Details |
| N-p-Coumaroyl-N'-caffeoylputrescine | C22H24N2O5 | 1138156-77-0 | Details |
| (S)-5-Pyridin-3-yl-pyrrolidin-2-one | C9H10N2O | 5980-06-3 | Details |
| Ethyl 2-(4-{[(tert-butoxy)carbonyl]amino}piperidin-1-yl)acetate | C14H26N2O4 | 203662-91-3 | Details |
| Palmitoyl-L-carnitine chloride | C23H46ClNO4 | 18877-64-0 | Details |
| C11ORF74 antibody | Details |
| 2,2,2-Trifluoro-1-[4-(trifluoromethoxy)phenyl]ethan-1-amine | C9H7F6NO | 1270479-61-2 | Details |
| 5-(Chloromethyl)-3-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazole | C10H8ClF2NO | 1334146-85-8 | Details |
| aS1810722 | C25H25F2N7O | 909561-15-5 | Details |
| Pf-04455242 hydrochloride | C21H29ClN2O2S | 1322001-35-3 | Details |
| M2/3E BPO Antibody Positive Human Plasma | Details |
| Bavachinin A | C21H22O4 | 19879-30-2 | Details |
| 2-Methylcyclopentane-1,3-dione | C6H8O2 | 765-69-5 | Details |
| H-Ala-Phe-Gly-OH | C14H19N3O4 | 20807-28-7 | Details |
| 2,6-Di-tert-butyl-p-cresol | C15H24O | 128-37-0 | Details |
| 2-(2-Phenylethenesulfonamido)acetic acid | C10H11NO4S | 202805-22-9 | Details |
| 4-Iodo-1-isopropyl-1H-pyrazole-3-carboxylic acid methyl ester | C8H11IN2O2 | 1354705-11-5 | Details |
| HIF3A antibody | Details |
| Yuexiandajisu D | C20H30O5 | 866556-15-2 | Details |
| 3-Nitro-1H-pyrazole-4-carboxylic acid | C4H3N3O4 | 39196-96-8 | Details |
| H-YPWTQRF-OH | Details |
| Sodium pyroantimonate | C5H4Na3O6Sb | 12507-68-5 | Details |
| 3-(3,5-Dimethyl-1H-pyrazol-4-yl)morpholine | C9H15N3O | 1367699-23-7 | Details |
| Cholesteryl nonadecanoate | C46H82O2 | 25605-90-7 | Details |
| RO-9187 | C9H12N6O5 | 876708-03-1 | Details |
| (S)-Methyl 4-oxoazetidine-2-carboxylate | C5H7NO3 | 100188-44-1 | Details |
| 2-(Morpholin-4-yl)-4-phenyl-1,3-thiazole-5-carbaldehyde | C14H14N2O2S | 129880-85-9 | Details |
| 2-Benzyl-1,3-benzoxazol-6-amine | C14H12N2O | 1152529-22-0 | Details |
| Cresyl glycidyl ether | C10H12O2 | 26447-14-3 | Details |
| 2,4-Dicyano-3-(3,4-dihydroxy-5-nitrophenyl)-N1,N1,N5,N5-tetraethylpentanediamide | C21H27N5O6 | Details |
| Sordarin sodium salt | C27H39O8.Na | 463356-00-5 | Details |
| 2-(4-Chloro-2-sulfamoylphenoxy)acetamide | C8H9ClN2O4S | 4527-62-2 | Details |
| Perakine | C21H22N2O3 | 4382-56-3 | Details |
| SIVmac239 - 24 | C79H135N27O23 | Details |
| 1-(2-Methylpropyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid | C11H13N3O2 | 926195-05-3 | Details |
| Ethyl 5-cyclopentyl-1,2-oxazole-3-carboxylate | C11H15NO3 | 908856-65-5 | Details |
| p-Hydroxyhippuryl-His-Leu-OH | C21H27N5O6 | 77697-23-5 | Details |
| FAM9B antibody | Details |
| 2-Fluoro-5-(1-methyl-1H-pyrazol-4-yl)benzoic acid | C11H9FN2O2 | 1179041-10-1 | Details |
| ME1 antibody | Details |
| 5-Bromo-4-methyl-2-(methylsulfanyl)pyridine | C7H8BrNS | 247135-44-0 | Details |
| -1(Pyrimidin-2-Yl)Ethan-1-Ol | C6H8N2O | 53342-30-6 | Details |
| S100A9 Blocking Peptide | Details |
| SMC1A antibody | Details |
| 5-nitro-2-(8-quinolyloxy)benzenecarbonitrile | C16H9N3O3 | 1022732-56-4 | Details |
| [Cys(Npys)]-TKD (450-463) | Details |
| RPL21 antibody | Details |
| 3-{[(tert-butoxy)carbonyl](propan-2-yl)amino}propanoic acid | C11H21NO4 | 917202-02-9 | Details |
| 5H,6H,7H-Pyrrolo[3,4-b]pyridine-2-carboxylic acid hydrochloride | C8H8N2O2 | 1955554-60-5 | Details |
| 2-(4-Fluoro-2-methylphenyl)-2-propoxyacetic acid | C12H15FO3 | 1548413-11-1 | Details |
| 2-[(Dimethyl-1,3-thiazol-2-yl)methyl]-2,3-dihydro-1H-isoindole-1,3-dione | C14H12N2O2S | 1444694-56-7 | Details |
| UGT2B15 antibody | Details |
| 1-(4-Amino-2-methylphenyl)-1H-pyrrole-2-carboxylic acid | C12H12N2O2 | 1240529-13-8 | Details |
| STX8 antibody | Details |
| 2-{4-[(Morpholin-4-yl)methyl]phenyl}ethan-1-amine | C13H20N2O | 669002-55-5 | Details |
| Ethyl (1,3-thiazol-2-ylcarbamothioyl)carbamate | C7H9N3O2S2 | 39142-41-1 | Details |
| 2-Methyl-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine | C7H11N3 | 1282597-36-7 | Details |
| Sucrose octasulfate triethylammonium salt | C18H37NO35S8 | 869561-07-9 | Details |
| Methyl 4-(Trimethylsilyl)benzoate | C11H16O2Si | 22515-30-6 | Details |
| 5-[(4-Aminophenyl)methyl]imidazolidine-2,4-dione | C10H11N3O2 | 132458-42-5 | Details |
| Chugai 3d | C22H21N3O3 | 1415388-25-8 | Details |
| Cyanodibenzylamine | C15H14N2 | 2451-91-4 | Details |
| KR-12-a5 (6-DL) | Details |
| Ethyl 6-bromo-8-chloro-4-hydroxy-quinoline-3-carboxylate | C12H9BrClNO3 | 217316-19-3 | Details |
| Warangalone | C25H24O5 | 4449-55-2 | Details |
| IPP1 protein (His tag) | Details |
| 1-Benzyl-1H-pyrazole-3-carbaldehyde | C11H10N2O | 321405-31-6 | Details |
| Ethyl 2-(2-aminoethyl)-1,3-thiazole-4-carboxylate hydrobromide | C8H13BrN2O2S | 1803584-70-4 | Details |
| H-TYKAAVDLSHFLKEK-OH | Details |
| Cortactin antibody (Tyr466) | Details |
| 5-Amino-3-methylpyridine-2-carboxylic acid hydrochloride | C7H8N2O2.ClH | 2248352-52-3 | Details |
| 1,4-Dimethyl-3,4-dihydro-2,7-naphthyridine | C10H12N2 | 87870-26-6 | Details |
| Product Total： Product Page： | ||||
| 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 | ||||